‘Huge scope for opportunities in biotech’

Students told to hone their skills to be industry-ready

August 11, 2017 12:52 am | Updated 12:52 am IST - VISAKHAPATNAM

Vice-Chairman of APEDB Pharma and Biotech Task Force Lanka Srinivas lighting a lamp to inaugurate ‘AP Bio-2017’ in Visakhapatnam on Thursday.

Vice-Chairman of APEDB Pharma and Biotech Task Force Lanka Srinivas lighting a lamp to inaugurate ‘AP Bio-2017’ in Visakhapatnam on Thursday.

After IT, biotechnology is another emerging area and there are several opportunities in store for the aspirants as the country is gearing up for the biotech boom.

Experts who assembled at GITAM University at the inaugural of the two-day international conference ‘AP Bio-2017’ on Thursday told the delegates and students to hone their skills to be industry ready.

Organised jointly by the Andhra Pradesh Economic Development Board (APEDB) GITAM Biotech Centre of Excellence, the conference saw a number of delegates from across the country taking part in the event.

Vice-Chairman of APEDB Pharma and Biotech Task Force Lanka Srinivas said that 50% of the research in pharmacy was based on biotechnology. He added that the country will play a key role in the field in the coming years.

Former Director General of Indian Council for Medical Research N.K. Ganguly said that there was a need to develop expertise to meet the growing demand in biotechnology.

Professor in Department of Radiation Oncology and Radiology of the Stanford University School of Medicine, USA Sanjay Malhotra said Andhra Pradesh comprised rich resources and there was a need to capitalise the available resources to transform the State into an economic zone.

Vice-Chancellor of GITAM University M.S. Prasada Rao also spoke.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.